Article Information
vol. 6 no. 243 243ra88
- Received for publication March 11, 2014
- Accepted for publication April 30, 2014
- .
Author Information
- Amarendra Pegu1,
- Zhi-yong Yang1,
- Jeffrey C. Boyington1,
- Lan Wu1,
- Sung-Youl Ko1,
- Stephen D. Schmidt1,
- Krisha McKee1,
- Wing-Pui Kong1,
- Wei Shi1,
- Xuejun Chen1,
- John-Paul Todd1,
- Norman L. Letvin1,2,*,
- Jinghe Huang3,
- Martha C. Nason4,
- James A. Hoxie5,
- Peter D. Kwong1,
- Mark Connors3,
- Srinivas S. Rao1,
- John R. Mascola1,† and
- Gary J. Nabel1,†
- 1Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), 40 Convent Drive, Bethesda, MD 20892, USA.
- 2Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, RE113, P. O. Box 15732, Boston, MA 02115, USA.
- 3HIV-Specific Immunity Section, Laboratory of Immunoregulation, NIAID, NIH, Bethesda, MD 20892, USA.
- 4Biostatistics Research Branch, NIAID, NIH, Bethesda, MD 20892, USA.
- 5Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- ↵†Corresponding author. E-mail: jmascola{at}nih.gov (J.R.M.); gary.nabel{at}sanofi.com (G.J.N.)